Metraipolis › archive › dc_2c73336238eb

Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition — Europe PMC PMID:41834581

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41834581
DOI
10.4014/jmb.2512.12029
License (as archived)
solo-consultazione
Archived
2026-11-04T11:17:53.835Z
SHA-256 of the archived text
336ac75b2fba96306d43a7b5c7bd17b6881acd129eb012e4f314f5f92a364cfe
Stable URL of this page
https://metraipolis.com/documento/dc_2c73336238eb

How to cite

Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition — Europe PMC PMID:41834581 — Europe PMC (en), https://europepmc.org/article/MED/41834581 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2c73336238eb (Metraipolis archive dc_2c73336238eb, sha256 336ac75b2fba96306d43a7b5c7bd17b6881acd129eb012e4f314f5f92a364cfe)
BibTeX
@misc{dc2c73336238eb,
  title = {Oncogenic GPR161 Drives Melanoma Proliferation and Metabolic Activity through TXNIP Inhibition — Europe PMC PMID:41834581},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41834581},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2c73336238eb; sha256 336ac75b2fba96306d43a7b5c7bd17b6881acd129eb012e4f314f5f92a364cfe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41834581. Agents can read the archived copy with the MCP tool read_document.